Clinical Trials Browser

OTHER × Leukemia × revumenib × Clear all

NCT06229912 2026-02-19

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia

NCT07356154 2026-01-21

A Study of Revumenib and Mezigdomide in People With Leukemia

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06313437 2025-03-27

Revumenib in Combination With 7+3 + Midostaurin in AML

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute